On Sunday night, the Oklahoma City Thunder will host the New York Knicks in a highly anticipated primetime matchup on NBC. NBA fans could expect Thunder point guard Shai Gilgeous-Alexander to stand ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Built with a neuroscience-inspired design at its core, the Mind 001 blends sensory innovation with a sleek, minimalist mule aesthetic. The molded upper is entirely enveloped in the titular “Pearl Pink ...

This year, a pair of new shoes from Nike and a pair of glasses from Ray Ban, created in partnership with Meta, have become hot topics for small talk among those who have embraced the active lifestyle.

View post: Michigan's Trey McKenney Makes Announcement on Tuesday Late last year Nike teased a new slide that would feature 22 foam nodes that contributed to stimulating the bottom of your foot to ...

WALKERTON - Brockton’s parks and recreation department will be able to utilize the former Ministry of Transportation (MTO) Yard facility for storage of equipment including machinery, garbage bins, ...

The Ontario Ministry of Transportation says it's reviewing winter maintenance operations at the time of a fatal accident Monday morning where a vehicle drove over a snowbank on the Highway 7 flyover ...

Plays and records audio cassettes. A sleek, modern design made from quality components, with powerful bass and full-range sound. The amber, backlit VU meters are both beautiful and practical. No radio ...

Nike is dropping the new Mind 001 pregame mules and this mind-altering design is going to be hard to get your hands on. The Mind 001 pregame mule is officially releasing on Jan. 8 at 10 a.m. ET. The ...

ORKA’s main bet is by targeting psoriasis with ultra-durable biologics like ORKA-001 (IL-23) in Phase 2a and ORKA-002 (IL-17A/F) in Phase 1. ORKA-001 could offer significant clinical benefits with ...

—AZR-MD-001 is a Potential First-in-Class Therapy Targeting Meibomian Gland Dysfunction (MGD), the Root Cause of Dry Eye Disease (DED) and Contact Lens Discomfort (CLD)— TEL AVIV, Israel--(BUSINESS ...